Healthtech/News/ Virtual fertility clinic Apricity raises €17m It plans to expand to Spain and launch at-home ultrasounds By Amy Lewin 5 September 2022 \Healthtech Is Daniel Ek’s new body scanner worth the hype? Sifted tried it out By Mimi Billing 17 February 2023 Healthtech/News/ Virtual fertility clinic Apricity raises €17m It plans to expand to Spain and launch at-home ultrasounds By Amy Lewin 5 September 2022 Apricity, a UK-based fertility startup which has seen revenue double in the past year, has raised a €17m Series B. It’s heading after a big — and growing — sector: the global fertility market is predicted to hit $26bn in the next five years. What does Apricity do? Apricity, which launched in 2019, offers a range of digital and at-home services for people who are struggling to conceive, which include consultations and diagnostics tests. It also has an app, which provides extra information on fertility issues and offers packages for egg freezing, IVF and egg donation, among others. It says it has a 46% success rate per cycle, in comparison to the UK average of 31%, and hugely cuts down on the number of trips to clinics that patients have to make. Apricity says the increased success rate is in part because its app helps people ensure they are, for example, taking the right drug at the right time in exactly the right dosage. It also says that treating people at home reduces the stress of the whole experience. In the future, it plans to offer at-home ultrasound scans too. Apricity’s customers are everyday people — and their employers. Its services are offered as employee benefits via organisations like AXA and Reward Gateway. This currently generates a third of the startup’s income. The investors MTIP, a Swiss healthtech investor, led the round. Iris Ventures, a Barcelona-based consumer fund, also participated. What’s next? In May this year, Apricity acquired Madrid-based period tracking app Woom. It plans to launch in Spain by the end of 2022, and also has Germany and Italy in its sights too. It now has a team of 50, but plans to double that by the end of 2023. The at-home fertility market Perhaps the biggest name in the sector is Carrot Health, a US-based employee fertility startup that’s raised over $100m from investors including Tiger Global. In Europe, there’s also: Hertility, which offers at-home hormone and fertility testing Gaia Fertility, which offers IVF insurance and is backed by Atomico Mojo, which offers at-home sperm testing. Amy Lewin is Sifted’s editor and cohost of The Sifted Podcast. She tweets from @amyrlewin Related Articles Exclusive: Barkibu raises $5.6m to become the Apple Health of pets By Maija Palmer Click here to read more These European B2B & SaaS leaders share their recipes for success Supported by B2B Rocks OLD Click here to read more Otrium raises €24m to expand its fashion marketplace By Michael Stothard Click here to read more These are Europe’s top startups tackling menopause By Miriam Partington in Berlin Click here to read more Most Read 1 \Healthtech Is Daniel Ek’s new body scanner worth the hype? Sifted tried it out 2 \Venture Capital VC diversity needs to change — and white men need to take responsibility 3 \Venture Capital New €3.75bn European Investment Fund pot to back late-stage VCs 4 \Sustainability Counteract closes £15m fund for carbon removal solutions 5 \Mobility Was the $5bn that VCs plugged into escooters worth it?